Current News

Country:
Operation:
Search for:
Overview Companies Countries Top News Tag Clouds
All   Business   Career   Cooperation   Finances   Laws   Manufacturing   Market
People   Politics   Price Development   Products   Research   Technology

Contact | Print version | Send article | RSS-FeedRSS feed

Ferro Announces Agreement to Sell Fine Chemical Business for $ 66 Million in Cash

07 Oct 2008 - Ferro Corporation announced that it has signed an asset purchase agreement with Novolyte Technologies LP, an affiliate of Arsenal Capital Management LP, to sell its Fine Chemicals business for $66 million in cash.

 
"This sale is consistent with our vision of focusing Ferro’s businesses around our core capabilities of particle engineering, formulation, color and glass science, and our deep understanding of customer applications,” said Ferro Chairman, President and Chief Executive Officer James F. Kirsch. "The decision to sell the business is a result of a regular review of our business portfolio. Fine Chemicals consists of a number of smaller businesses that do not effectively leverage the scale of Ferro’s core performance materials operations. I am confident that the Fine Chemicals business will continue to pursue many exciting opportunities under its new owners. At the same time, Ferro will benefit from additional liquidity and balance sheet flexibility as proceeds from the sale are used to reduce debt.”
 
The Fine Chemicals business produces electrolytes used in the manufacture of lithium batteries, specialty solvents, and phosphines and also does contract manufacturing of fine chemicals. It recorded 2007 revenues of approximately $55 million and currently employs approximately 140 employees who will be transferred to Novolyte as a result of the sale. The business includes manufacturing facilities in Baton Rouge, Louisiana and Suzhou, China.
 
The agreement is subject to normal closing conditions and the sale is expected to close in the fourth quarter of 2008. KeyBanc Capital Markets served as Ferro’s financial advisor and investment banker for this transaction.
 
Contact / Request Information
Additional information
MyChemEurope.COM
Newsletter Subscription
Your e-mail:
Top  
© 2006-2008 Chemie.DE Information Service GmbH
a Life Science Network Division

 www.Bionity.COM   www.ChemEurope.COM   www.Quimica.ES   www.ChemieKarriere.NET   www.BioKarriere.NET